Offer - Urjas Oil for just ₹ 1 X
Revlamer 400 Mg Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Increased Phosphate Levels in the Blood. Secondary and off-label uses of Revlamer 400 Mg Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Revlamer 400 Mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Revlamer 400 Mg Tablet have been listed ahead. Such side effects of Revlamer 400 Mg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Revlamer 400 Mg Tablet has a Unknown effect for pregnant women and Safe effect on lactating mothers. In addition, Revlamer 400 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Revlamer 400 Mg Tablet related warnings section.
Revlamer 400 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Intestinal Obstruction are examples of such conditions. Other contraindications of Revlamer 400 Mg Tablet have been discussed in the sections ahead.
Additionally, Revlamer 400 Mg Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Revlamer 400 Mg Tablet, it is important to know that it is safe while driving, and is habit-forming.
Revlamer 400 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Revlamer 400 Mg Tablet safe for pregnant women?
No research has not been done till date on the safety of Revlamer for pregnant women. So its effects on pregnant women are unknown.
Is the use of Revlamer 400 Mg Tablet safe during breastfeeding?
Revlamer is completely safe for breastfeeding women.
What is the effect of Revlamer 400 Mg Tablet on the Kidneys?
Revlamer may have mild side effects on the kidneys.
What is the effect of Revlamer 400 Mg Tablet on the Liver?
Information about safety of Revlamer for the liver is not available since scientific research on this is yet to be done.
What is the effect of Revlamer 400 Mg Tablet on the Heart?
Information about safety of Revlamer for heart is not available since scientific research on this is yet to be done.
If you are suffering from any of the following diseases, you should not take Revlamer 400 Mg Tablet unless your doctor advises you to do so -
Is this Revlamer 400 Mg Tablet habit forming or addictive?
Forming a habit of Revlamer 400 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Revlamer 400 Mg Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume Revlamer 400 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Revlamer 400 Mg Tablet in mental disorders is not effective.
Interaction between Food and Revlamer 400 Mg Tablet
Due to the absence of research, it is difficult to say how Revlamer 400 Mg Tablet and food will interact.
Interaction between Alcohol and Revlamer 400 Mg Tablet
Due to lack of research, there is no information about the side effects of taking Revlamer 400 Mg Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135